J 2023

Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature

GONZALEZ-RIVAS, Juan P., Iuliia PAVLOVSKA, Anna POLCROVÁ, Ramfis NIETO-MARTINEZ, Jeffrey I. MECHANICK et. al.

Základní údaje

Originální název

Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature

Autoři

GONZALEZ-RIVAS, Juan P. (garant), Iuliia PAVLOVSKA (804 Ukrajina, domácí), Anna POLCROVÁ (203 Česká republika, domácí), Ramfis NIETO-MARTINEZ a Jeffrey I. MECHANICK

Vydání

AMERICAN JOURNAL OF LIFESTYLE MEDICINE, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2023, 1559-8276

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.900 v roce 2022

Kód RIV

RIV/00216224:14110/23:00130012

Organizační jednotka

Lékařská fakulta

UT WoS

000806385700001

Klíčová slova anglicky

dysglycemia; culture; lifestyle medicine; prevention; transcultural; type 2 diabetes

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 26. 1. 2024 10:10, Mgr. Tereza Miškechová

Anotace

V originále

Disparities in type 2 diabetes (T2D) care is a global problem across diverse cultures. The Dysglycemia-Based Chronic Disease (DBCD) model promotes early and sustainable interventions along the insulin resistance (stage 1), prediabetes (stage 2), T2D (stage 3), and complications (stage 4) spectrum. In this model, lifestyle medicine is the cornerstone of preventive care to reduce DBCD progression and the socioeconomic/biological burden of disease. A comprehensive literature review, spanning 2000 to 2021, was performed and 55 studies were included examining the effects of lifestyle medicine and their cultural adaptions with different prevention modalities. In stage 1, primordial prevention targets modifiable primary drivers (behavior and environment), unhealthy lifestyles, abnormal adiposity, and insulin resistance with educational and motivational health promotion activities at individual, group, community, and population-based scales. Primary, secondary, and tertiary prevention targets individuals with mild hyperglycemia, severe hyperglycemia, and complications, respectively, using programs that incorporate structured lifestyle interventions. Culturally adapted lifestyle change in primary and secondary prevention improved quality of life and biomarkers, but with a limited impact of tertiary prevention on cardiovascular events. In conclusion, lifestyle medicine with cultural adaptations is an integral part of preventive care in patients with T2D. However, considerable research gaps exist, especially for tertiary prevention.